The FDA on Monday approved the first-ever GLP-1 pill from Novo Nordisk. The approval gives the Danish pharma giant a head start against U.S. rival Eli Lilly. "Novo actually might have an edge, and it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results